Department of Chemistry, University at Buffalo, Buffalo, NY 14260, United States.
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1648-51. doi: 10.1016/j.bmcl.2010.01.076. Epub 2010 Jan 21.
The design and synthesis of 5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil (AIFU), a potent inhibitor of thymidine phosphorylase (TP) with K(i)-values of 11nM (ecTP) and 17nM (hTP), are described. Kinetic studies established that the type of inhibition of TP by AIFU is uncompetitive with respect to inorganic phosphate (or arsenate). The results obtained suggest that AIFU and other zwitterionic thymine analog inhibitors of TP act as transition state analogs, mimicking the anionic thymine leaving group, consistent with an S(N)2-type catalytic mechanism, and anchored by their protonated side chains to the enzyme-bound phosphate by electrostatic and H-bonding interactions.
5-氟-6-[(2-氨基咪唑-1-基)甲基]尿嘧啶(AIFU)的设计和合成,它是胸苷磷酸化酶(TP)的一种有效抑制剂,对 ecTP 和 hTP 的 K(i)值分别为 11nM 和 17nM。动力学研究表明,AIFU 对 TP 的抑制类型是对无机磷酸盐(或砷酸盐)的非竞争性抑制。所得结果表明,AIFU 和其他 TP 的两性嘧啶类似物抑制剂作为过渡态类似物起作用,模拟阴离子胸腺嘧啶离去基团,与 S(N)2 型催化机制一致,并通过其质子化侧链通过静电和氢键相互作用与酶结合的磷酸盐结合。